One Year Of Rheuma Tv

Today marks the one-year anniversary of Rheuma Tv’s launch. We are delighted to celebrate our anniversary with everyone. RheumaTv was launched to empower rheumatology specialists and physicians with a keen interest in rheumatology. It offers academic information for UG and PG students, clinically challenging case studies, journal reviews, quizzes, webinars, and expert talks by healthcare professionals and experts. We also have a rheumatology calculator where you can measure various rheumatological conditions. Several informational webinar series were conducted on various topics such as immunology & inflammation, investigations in rheumatology, tofacitinib in rheumatology, and Conventional DMARDs in rheumatoid arthritis. We thank our sponsors for their support.

The upcoming events include “Annual training program on biostatistics and research methodology workshop- 2022”, a webinar on the “use of biologics in rheumatology”, live case discussions, expert views & symposiums on various topics. Sign up/register with us to receive information on the various programs available on our website.

Most Viewed

Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Expert Talk: Newer therapies of Gout
Lecture on IgG4RD by John H. Stone
JAK Inhibitor_ a concept to utility in the management of Autoimmune Disease by Dr. Puja Srivastava
Investigations in Rheumatology Series- 7 ANCA – Methods, Techniques & its role in Rheumatology
Investigation in Rheumatology, Session – 2
Expert Talk : Uric acid-Hyperuricemia-Gout-a Metabolic to a Rheumatological disease
Eye and Rheumatology Series : Ocular Surface Inflammation
09 – Utility of scleroderma specific autoantibodies in diagnosis & management
Tofacitinib_indications & its use in Rheumatolgy by Dr. Raj Kiran, Hyderabad
 

Latest Posts

Rheumatoid Arthrits

Is rheumatoid arthritis two different diseases?
Finally! a definition for difficult-to-treat rheumatoid arthritis
Guidelines for the treatment of rheumatoid arthritis
Are we going to have vaccine for rheumatoid arthritis?
Researchers identify mitochondrial proteins linked to T cell dysfunction in rheumatoid arthritis
Study validates the superiority of denosumab over bisphosphonates in managing rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Cells from a cheek swab may serve as biomarkers for female rheumatoid arthritis
DMARDSs do not reduce the risk for Parkinson disease in rheumatoid arthritis patients
Lipidomics profiling may serve as a biomarker for disease evolution and activity in rheumatoid arthritis
Power Doppler ultrasound effective in predicting rheumatoid arthritis
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Should we vaccinate high risk rheumatic disease with third booster dose?
The effect of baricitinib in uncoupling the disease activity and structural damage progression in RA
American College of Rheumatology releases newer guidelines for the perioperative management of RA patients undergoing total knee arthroplasty
Behcet’s disease is linked to Multiple sclerosis and rheumatoid arthritis
Can IL 11 be the new potential target in RA with ILD?
Passive smoking can function as an elevated risk factor for RA in women
Computer Vision an effective tool for quantifying synovial inflammation in rheumatoid arthritis
Two-week methotrexate discontinuation helps to improve the SARS-CoV-2 vaccine efficacy in RA patients
Switching between JAK inhibitors could be beneficial in certain subset of RA patients
Concomitant administration of tacrolimus and biological DMARDS, a potential rescue therapy in rheumatoid arthritis
Prevalence of multimorbidities in RA patients
Impact of smoking and alcohol on rheumatic and musculoskeletal disease
Researchers propose suggestions to guide the safer use of methotrexate in RA patients
Early methotrexate treatment can modify the disease course of RA
Anti-SSA antibody positivity could be predictive of treatment response in RA patients
Tofacitinib treatment is better after conventional DMARDs in RA patients
ORAL Surveillance trial findings report increased infections in RA patients receiving tofacitinib
Olokizumab, a new drug for managing rheumatoid arthritis
Researchers identify sulfatase-2 as key protein that drives rheumatoid arthritis damage
Molecular signature-assisted drug selection helps in improving therapeutic response in RA
Unincreased hospitalization risk in elderly rheumatoid arthritis patients undergoing targeted therapy
Treat to target in Rheumatoid Arthritis series – 1
A 34-year-old female with 10 years history of rheumatoid arthritis, frequent episodes of fever, and weight loss
A 52-year-old male with 10 years history of rheumatoid arthritis presented to the clinic with worsening pain and swelling in joints
Sudden Worsening of Pain in the Left Ankle in Rheumatoid Arthritis, Diabetes
61- year-old female school teacher, experiencing pain and early morning stiffness for the past 6 years
Investigation in Rheumatology, Session – 2
Investigations in Rheumatology Series 4: Conventional Radiology in Rheumatology by Dr. URK RAO
Investigation in Rheumatology series-5
Investigations in Rheumatology Series – 6 (MRI in Rheumatology)
Cs DMARDS in Rheumatoid Arthritis,Lecture1 Introduction to DMARDs A concept to current understanding
Conventional DMARDS in Rheumatoid Arthritis , Lecture 2: Pre-evaluation for use of DMARDs
Lecture 3 Methotrexate:- Pharmacology, pharmacodynamics and mechanism
Conventional DMARDS in Rheumatoid Arthritis, Lecture 4 Clinical use of Methotrexate in Rheumatology
CS DMARDS in Rheumatoid Arthritis, Safety concern, precautions and management of adverse events
Lecture 6: CS DMARDs, Hydroxychloroquine :- Pharmacology, pharmacodynamics and mechanism
Lecture 7: CS DMARDs, Hydroxychloroquine, Clinical use in Rheumatology- Safety concern, Precautions and Management
CS DMARDS in Rheumatoid Arthritis: Leflunomide – Pharmacology, Pharmacodynamics and Mechanism
Leflunomide- Clinical use in rheumatology- SafetyConcern, Precautions & Management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Sulfasalazine – Pharmacology, Pharmacodynamics and Mechanism
Sulfasalazine Clinical use in Rheumatology Safety concern precautions & management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Iguratimod – Pharmacology, Pharmacodynamics and Mechanism
Iguratimod – Clinical use in rheumatology- Safety concern, precautions& management of adverse events
CS DMARDS in Rheumatoid Arthritis: Other DMARDs – Azathioprine,cyclosporine,D-penicillamine and Gold
Approach To Diagnosis And Treatment Of Rheumatoid Arthritis
Immunomodulators in Rheumatoid Arthritis
DAS28-ESR for Rheumatoid Arthritis
DAS28-CRP for Rheumatoid Arthritis
Simplified Disease Activity Index for RA (SDAI)
Clinical Disease Activity Index for RA (CDAI)

Covid - 19

Should child with arthritis be prioritized and get Covid-19 vaccine
Patients treated with anti- B cell therapy have a higher risk of  COVID -19 death
Risk of COVID-19 infection with Interstitial Lung Disease
Good news! no link between COVID-19 vaccines and arthritis flare
Second COVID vaccine improves the serological response in patients with autoimmune diseases
Covid-19 Hospitalisation Risk Factors in Patients With Anti-rheumatic Drugs Is No Way Different From Others
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Impact of COVID-19 infection on children and young people with rheumatic and musculoskeletal diseases
Safety and efficacy of third dose SARS COV -2 VACCINATION in patients on immunosuppressive therapy
COVID-19 vaccination is safe in patients with rheumatic diseases
 
T cell response to SARS-CoV-2 in infection and vaccination by Dr. Nimesh Gupta
Neurological Manifestations of COVID by Dr. Seena Vengalil
Adaptive Immune response to SARS-CoV2 infection and Vaccination by Dr. Amit Awasthi
Immune Response to COVID19 infection by Dr. Florian Krammer
Rheumatological Manifestations of COVID by Dr. Puja Srivastava
Ocular Manifestations of COVID by Dr. Padmamalini Mahendradas
Adaptive Immune response to SARS-CoV2 infection and Vaccination by Dr. Amit Awasthi
 

Eye diseases

Researchers explore the pattern of uveitis in routine ophthalmology practice in India
Quiz on anterior uveitis
Scleritis quiz part 2
First Round quiz on Scleritis
Eye and Rheumatology Series – Interactive session
Eye and Rheumatology Series : Ocular Surface Inflammation
Eye and Rheumatology Series: Dry Eye Conditions
Eye and Rheumatology Series – Episcleritis and Scleritis
Eye and Rheumatology Series – 4 : Anterior Uveitis
Ocular Inflammatory Disease – Introduction
Eye and Rheumatology Series- 5 Uveitis Part 2
Eye and Rheumatology Series- 6 Orbital Inflammation
Eye and Rheumatology Series- 8 Steroid induced opthol perspective & Rheumatologist perspective
Eye and Rheumatology Series- 7

Immunology

Second COVID vaccine improves the serological response in patients with autoimmune diseases
Patients treated with anti- B cell therapy have a higher risk of  COVID -19 death
Researchers identify mitochondrial proteins linked to T cell dysfunction in rheumatoid arthritis
29th April, the significance of International day of Immunology
Quiz on IgG4RD
Lecture on IgG4RD by John H. Stone
Adaptive Immune response to SARS-CoV2 infection and Vaccination by Dr. Amit Awasthi
Immune Response to COVID19 infection by Dr. Florian Krammer
[Day-1] Lecture Series 4 (Autoimmunity and Inflammation)
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Neuroinflammatory diseases – Clinical perspective
Immunopathological Mechanism of Neuroinflammatory Disease
Immune-mechanisms and Inflammations in Gastroenterology
Ocular Inflammatory Disease – Introduction
Immune-Mechanism Unique to Ophthalmic Associated Inflammations
Auto-immune mediated Inflammatory Skin Disorder – Introduction to Clinical Variety
Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin
[Day-1]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
T cell response to SARS-CoV-2 in infection and vaccination by Dr. Nimesh Gupta
Lecture Series on IMMUNOLOGY & INFLAMMATION Inflammation-Regulation and Therapeutic Implication
Immunomodulators in Rheumatoid Arthritis

Autoimmune disorders

Should we vaccinate high risk rheumatic disease with third booster dose?
Is rheumatoid arthritis two different diseases?
Guidelines for the treatment of rheumatoid arthritis
Are we going to have vaccine for rheumatoid arthritis?
Researchers identify mitochondrial proteins linked to T cell dysfunction in rheumatoid arthritis
Oral microbiome influences the risk of developing rheumatoid arthritis
Study validates the superiority of denosumab over bisphosphonates in managing rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Cells from a cheek swab may serve as biomarkers for female rheumatoid arthritis
Favorable benefit-risk ratio of upadacitinib compared to adalimumab for managing moderate-to severe RA
Second COVID vaccine improves the serological response in patients with autoimmune diseases
Human leukocyte antigen-B27 status is not suggestive of treatment response in psoriatic arthritis axial disease
DMARDSs do not reduce the risk for Parkinson disease in rheumatoid arthritis patients
Researchers validate the role of serum biomarkers in determining disease activity of ANCA-associated vasculitis
Researchers explore the pattern of uveitis in routine ophthalmology practice in India
Myositis specific antibodies to predict treatment response in idiopathic inflammatory myopathies
Metabolomic profiling in RA may help identifying patients prone to ILD
Etanercept tapering is feasible without compromising the efficacy in patients with autoimmune disease
Mood disorders and fibromyalgia impair the cognitive function in SLE patients
C‑reactive protein isoforms help to differentiate between SLE quiescent and active phenotypes
Can Iberodomide be a novel drug in SLE management?
Case of 34-year-old female – polyarthritis and erythematous skin rash – 29/03/2022
A 55-year-old female with left knee pain for 15 years, neck and low back pain
A 34-year-old female with 10 years history of rheumatoid arthritis, frequent episodes of fever, and weight loss
41-yr-old male with 6 month history of joint pain, severe diarrhea and low back pain
28-year-old male paramedic with a history of joints and back pain – dry skin – 27/04/2022
A 34-year-old female – lower back pain and dry eye – 13/03/2022
65-year-old female patient with progressive mono neuritis multiplex and a history of pain in upper and lower limbs – 04/05/2022
48-year-old female admitted to emergency with difficulty in getting up from a sitting position, nausea and a mild increase in pain
61- year-old female school teacher, experiencing pain and early morning stiffness for the past 6 years
A 28-year-old female, experiencing skin rashes and bilateral knee pain from past 15 days, presented to the clinic
23-year-old female with a two-year history of neck pain and polyarthritis, dry mouth, hair loss, and skin rashes – 11/05/2022
28 years old female with fever, malar rash, dryness of mouth, and burning sensation in eyes
 Series- 7 ANCA – Methods, Techniques & its role in Rheumatology
[Day-1] Lecture Series 4 (Autoimmunity and Inflammation)
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Neuroinflammatory diseases – Clinical perspective
Immunopathological Mechanism of Neuroinflammatory Disease
Immune-mechanisms and Inflammations in Gastroenterology
Ocular Inflammatory Disease – Introduction
Immune-Mechanism Unique to Ophthalmic Associated Inflammations
Auto-immune mediated Inflammatory Skin Disorder – Introduction to Clinical Variety
Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin
[Day-1]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Eye and Rheumatology Series – 4 : Anterior Uveitis
Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Approach To Diagnosis And Treatment Of Rheumatoid Arthritis
Interpreting tests in Rheumatology by Dr. Chandrashekara S
Raynaud’s- History, evaluation and management
Immunomodulators in Rheumatoid Arthritis
Named signs in Rheumatology
SLICC/ACR Damage Index Measure accumulated damage since onset of lupus
SLICC SLE Criteria – The SLICC criteria are validated criteria for making the diagnosis of lupus
SLEDAI-2K (Assess disease activity in lupus)

Uveitis

Researchers explore the pattern of uveitis in routine ophthalmology practice in India
Quiz on anterior uveitis
MCQ questions for posterior uveitis
 
Eye and Rheumatology Series – 4 : Anterior Uveitis
Ocular Inflammatory Disease – Introduction
Immune-Mechanism Unique to Ophthalmic Associated Inflammations
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Eye and Rheumatology Series- 5 Uveitis Part 2

DMARDS

Finally! a definition for difficult-to-treat rheumatoid arthritis
Cardiovascular and malignancy risk with janus kinase inhibitor is it dose dependent
Oral tofacitinib safe and effective for managing juvenile idiopathic arthritis
Guidelines for the treatment of rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Favorable benefit-risk ratio of upadacitinib compared to adalimumab for managing moderate-to severe RA
Human leukocyte antigen-B27 status is not suggestive of treatment response in psoriatic arthritis axial disease
DMARDSs do not reduce the risk for Parkinson disease in rheumatoid arthritis patients
Covid-19 Hospitalisation Risk Factors in Patients With Anti-rheumatic Drugs Is No Way Different From Others
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
No association between targeted DMARDs and the risk of Alzheimer and related dementia
Long-term DMARD use in RA reduces the incidence of diabetes
FDA approves RINVOQ® (upadacitinib) for the management of ankylosing spondylitis
Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Cs DMARDS in Rheumatoid Arthritis,Lecture1 Introduction to DMARDs A concept to current understanding
Conventional DMARDS in Rheumatoid Arthritis , Lecture 2: Pre-evaluation for use of DMARDs
Lecture 3 Methotrexate:- Pharmacology, pharmacodynamics and mechanism
Conventional DMARDS in Rheumatoid Arthritis, Lecture 4 Clinical use of Methotrexate in Rheumatology
CS DMARDS in Rheumatoid Arthritis, Safety concern, precautions and management of adverse events
Lecture 6: CS DMARDs, Hydroxychloroquine :- Pharmacology, pharmacodynamics and mechanism
Lecture 7: CS DMARDs, Hydroxychloroquine, Clinical use in Rheumatology- Safety concern, Precautions and Management
CS DMARDS in Rheumatoid Arthritis: Leflunomide – Pharmacology, Pharmacodynamics and Mechanism
Leflunomide- Clinical use in rheumatology- SafetyConcern, Precautions & Management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Sulfasalazine – Pharmacology, Pharmacodynamics and Mechanism
Sulfasalazine Clinical use in Rheumatology Safety concern precautions & management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Iguratimod – Pharmacology, Pharmacodynamics and Mechanism
Iguratimod – Clinical use in rheumatology- Safety concern, precautions& management of adverse events
CS DMARDS in Rheumatoid Arthritis: Other DMARDs – Azathioprine,cyclosporine,D-penicillamine and Gold
Approach To Diagnosis And Treatment Of Rheumatoid Arthritis

ANCA

Researchers validate the role of serum biomarkers in determining disease activity of ANCA-associated vasculitis
Validated classification criteria for microscopic polyangiitis published for research settings
Quiz for ANCA
A 28-year-old female, experiencing skin rashes and bilateral knee pain from past 15 days, presented to the clinic
65-year-old female patient with progressive mono neuritis multiplex and a history of pain in upper and lower limbs – 04/05/2022
Investigations in Rheumatology Series- 7 ANCA – Methods, Techniques & its role in Rheumatology

COVID-19-RA

Should child with arthritis be prioritized and get Covid-19 vaccine
Should we vaccinate high risk rheumatic disease with third booster dose?
Good news! no link between COVID-19 vaccines and arthritis flare
Covid-19 Hospitalisation Risk Factors in Patients With Anti-rheumatic Drugs Is No Way Different From Others
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Rheumatological Manifestations of COVID by Dr. Puja Srivastava

Tofacitinib

Cardiovascular and malignancy risk with janus kinase inhibitor is it dose dependent
Oral tofacitinib safe and effective for managing juvenile idiopathic arthritis
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Tofacitinib treatment is better after conventional DMARDs in RA patients
Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Tofacitinib_indications & its use in Rheumatolgy by Dr. Raj Kiran, Hyderabad
JAK Inhibitor_ a concept to utility in the management of Autoimmune Disease by Dr. Puja Srivastava
Safety concerns, precautions and management of adverse events by Dr.Chandrashekara.S, Bengaluru

Autoantibodies

Myositis specific antibodies to predict treatment response in idiopathic inflammatory myopathies
Anti–IL-1 receptor antagonist autoantibodies stimulate inflammatory and fibrotic mediators in IgG4-related disease
 Series- 7 ANCA – Methods, Techniques & its role in Rheumatology
[Day-1] Lecture Series 4 (Autoimmunity and Inflammation)
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Neuroinflammatory diseases – Clinical perspective
Immunopathological Mechanism of Neuroinflammatory Disease
Immune-mechanisms and Inflammations in Gastroenterology
Ocular Inflammatory Disease – Introduction
Immune-Mechanism Unique to Ophthalmic Associated Inflammations
Auto-immune mediated Inflammatory Skin Disorder – Introduction to Clinical Variety
Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin
[Day-1]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Session – 2- investigation in Rheumatoid arthritis- Autoantibodies
 Series 1 – ANA
Use of Autoantibodies in diagnosis of Rheumatic Diseases by Dr. Chandrashekara S
09 – Utility of scleroderma specific autoantibodies in diagnosis & management
Investigations in Rheumatology: Role of Myositis Specific Autoantibodies in Diagnosis & Management

IgG4

Anti–IL-1 receptor antagonist autoantibodies stimulate inflammatory and fibrotic mediators in IgG4-related disease
Quiz on IgG4RD
Lecture on IgG4RD by John H. Stone

JAK inhibitor

Cardiovascular and malignancy risk with janus kinase inhibitor is it dose dependent
Oral tofacitinib safe and effective for managing juvenile idiopathic arthritis
Favorable benefit-risk ratio of upadacitinib compared to adalimumab for managing moderate-to severe RA
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
The effect of baricitinib in uncoupling the disease activity and structural damage progression in RA
FDA approves RINVOQ® (upadacitinib) for the management of ankylosing spondylitis
Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Tofacitinib_indications & its use in Rheumatolgy by Dr. Raj Kiran, Hyderabad
JAK Inhibitor_ a concept to utility in the management of Autoimmune Disease by Dr. Puja Srivastava
Safety concerns, precautions and management of adverse events by Dr.Chandrashekara.S, Bengaluru

Myositis specific antibodies

Experts highlight myositis-specific and associated autoantibody (MSA/MAA) testing in diagnosing idiopathic inflammatory myopathy
Myositis specific antibodies to predict treatment response in idiopathic inflammatory myopathies
Investigations in Rheumatology: Role of Myositis Specific Autoantibodies in Diagnosis & Management

Scleritis

First Round quiz on Scleritis
Scleritis quiz part 2
Ocular Inflammatory Disease – Introduction
Eye and Rheumatology Series – Episcleritis and Scleritis
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)

Dry eye disease

Immune-Mechanism Unique to Ophthalmic Associated Inflammations
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)

Interstitial lung disease

Risk of COVID-19 infection with Interstitial Lung Disease
Can IL 11 be the new potential target in RA with ILD?
Blood KL-6 predicts the prognosis in primary SJS-associated interstitial lung disease

Systemic lupus erythematosus

Mood disorders and fibromyalgia impair the cognitive function in SLE patients
C‑reactive protein isoforms help to differentiate between SLE quiescent and active phenotypes
Can Iberodomide be a novel drug in SLE management?
23-year-old female with a two-year history of neck pain and polyarthritis, dry mouth, hair loss, and skin rashes – 11/05/2022
28 years old female with fever, malar rash, dryness of mouth, and burning sensation in eyes
SLICC/ACR Damage Index Measure accumulated damage since onset of lupus
SLICC SLE Criteria – The SLICC criteria are validated criteria for making the diagnosis of lupus
SLEDAI-2K (Assess disease activity in lupus)

GOUT

Expert Talk : Uric acid-Hyperuricemia-Gout-a Metabolic to a Rheumatological disease
Expert Talk: Newer therapies of Gout
Lecture on Gout
Acute Gout Diagnosis Rule – Clinical decision tool to assist in the diagnosis of acute gout

Raynaud's phenomenon

Raynaud’s Phenomenon Quiz
 
Raynaud’s- History, evaluation and management

Axial spondyloarthritis

High CRP level and disease activity can predict cardiovascular disease in axial spondylarthritis patients
Evolving Paradigms in Axial Spondyloarthritis (AxSpA)

Ankylosing spondylitis

FDA approves RINVOQ® (upadacitinib) for the management of ankylosing spondylitis
Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S
Management of Ankylosing Spondylitis:- Recommendations & Practical Tips by Dr. Dr.Subramanian. R
ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score)
ASDAS-ESR (Ankylosing Spondylitis Disease Activity Score)
BASDAI Assess disease activity in Ankylosing Spondylitis